Katleen De Preter Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• An embryonic stem cell activated FOXM1 transcriptional program marks ultra-high-risk primary neuroblastoma patients for FDI-6 small molecule inhibition — Poster Session 1 with wine & cheese
• Detection of copy number aberrations in cell free DNA from plasma of neuroblastoma patients using shallow massive parallel sequencing  — Parallel 2 Liquid Biopsies, Circulating Tumour Cells and Metastasis
• Copy number profiles as prognostic marker for high-risk neuroblastoma patients — Workshop 4 - Next generation risk stratification: new approaches to identify highest risk patients (or ultra high risk patients)